August 22, 2023 03:07 PM EDT
Pharma
FDA+

FDA warns Ama­zon and Wal­mart over sale of un­ap­proved prod­uct

Tyler Patchen

News Reporter

The FDA has hand­ed warn­ing let­ters to both Ama­zon and Wal­mart for sell­ing an un­ap­proved med­ical prod­uct …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

Marks’ ex­it at FDA rat­tles an al­ready tee­ter­ing biotech in­dus­try

Lil­ly's heart dis­ease drug could be dosed as lit­tle as once a year, study shows

In­spir­na, which was prepar­ing for a Phase 3 can­cer tri­al, has fold­ed

What’s next af­ter Marks? At FDA, ques­tions over more top ex­its and fu­ture vi­sion for drug agency

Al­pha­bet’s Iso­mor­phic Labs rais­es $600M in biotech’s largest round of 2025 

sponsored

End­points we­bi­nar: In­side the “One Lon­za” strat­e­gy: Re-en­gi­neer­ing the fu­ture of CD­MO

A service from the Financial Times